Schizophrenia and weight management: a systematic review of interventions to control weight

被引:109
作者
Faulkner, G
Soundy, AA
Lloyd, K
机构
[1] Univ Toronto, Fac Phys Educ & Hlth, Toronto, ON M55 2W6, Canada
[2] Univ Exeter, Sch Sport & Hlth Sci, Exeter, Devon, England
[3] Peninsula Med Sch, Exeter, Devon, England
关键词
weight loss; schizophrenia; review;
D O I
10.1034/j.1600-0447.2003.00218.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Weight gain is a frequent side effect of antipsychotic medication which has serious implications for a patient's health and well being. This study systematically reviews the literature on the effectiveness of interventions designed to control weight gain in schizophrenia. Method: A systematic search strategy was conducted of major databases in addition to citation searches. Study quality was rated. Results: Sixteen studies met the inclusion criteria. Five of eight pharmacological intervention studies reported small reductions in weight (< 5% baseline body weight). All behavioural ( including diet and/or exercise) interventions reported small reductions in, or maintenance of, weight. Conclusion: Weight loss may be difficult but it is not impossible. Given the inconsistent results, the widespread use of pharmacological interventions cannot be recommended. Both dietary and exercise counselling set within a behavioural modi. cation programme is necessary for sustained weight control.
引用
收藏
页码:324 / 332
页数:9
相关论文
共 74 条
[51]   Metformin for weight loss in pediatric patients taking psychotropic drugs [J].
Morrison, JA ;
Cottingham, EM ;
Barton, BA .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (04) :655-657
[52]  
NGUYEN CT, 2001, AM PSYCH ASS ANN M 5
[53]   Management of overweight and obese adults [J].
Noël, PH ;
Pugh, JA .
BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7367) :757-761
[54]   The poor physical health of people with mental illness [J].
Osborn, DPJ .
WESTERN JOURNAL OF MEDICINE, 2001, 175 (05) :329-332
[55]   Physical health of people with severe mental illness - Can be improved if primary care and mental health professionals pay attention to it [J].
Phelan, M ;
Stradins, L ;
Morrison, S .
BRITISH MEDICAL JOURNAL, 2001, 322 (7284) :443-444
[56]  
Pi-Sunyer FX, 1998, OBES RES, V6, p51S
[57]   Attenuation of olanzapine-induced weight gain with reboxetine in patients with schizophrenia: A double-blind, placebo-controlled study [J].
Poyurovsky, M ;
Isaacs, I ;
Fuchs, C ;
Schneidman, M ;
Faragian, S ;
Weizman, R ;
Weizman, A .
AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02) :297-302
[58]   Olanzapine-induced weight gain in patients with first-episode schizophrenia: A double-blind, placebo-controlled study of fluoxetine addition [J].
Poyurovsky, M ;
Pashinian, A ;
Gil-Ad, I ;
Maayan, R ;
Schneidman, M ;
Fuchs, C ;
Weizman, A .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) :1058-1060
[59]   WEIGHT-LOSS WITH PSYCHIATRIC-RESIDENTS IN A BEHAVIORAL SELF-CONTROL PROGRAM [J].
ROTATORI, AF ;
FOX, R ;
WICKS, A .
PSYCHOLOGICAL REPORTS, 1980, 46 (02) :483-486
[60]   H2 antagonist nizatidine may control olanzapine-associated weight gain in schizophrenic patients [J].
Sacchetti, E ;
Guarneri, L ;
Bravi, D .
BIOLOGICAL PSYCHIATRY, 2000, 48 (02) :167-168